Related Experiment Video
Updated: May 19, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Cholesterol metabolism and colorectal cancers
Rutger J Jacobs1, Philip W Voorneveld, Ludmilla L Kodach
1Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.
Current Opinion in Pharmacology
|August 14, 2012
Summary
Colorectal cancer (CRC) is linked to cholesterol metabolism, sharing risk factors with cardiovascular disease. This review explores cholesterol
Area of Science:
- Oncology
- Metabolic Science
- Epidemiology
Background:
- Colorectal cancer (CRC) is a significant lifestyle-related disease in Western countries.
- CRC shares numerous risk factors with cardiovascular disease, highlighting interconnected health issues.
- The link between cholesterol metabolism and CRC is well-established, with ongoing research.
Purpose of the Study:
- To review current evidence connecting cholesterol metabolism and colorectal cancer.
- To summarize the molecular mechanisms underlying this association.
- To discuss implications for CRC prevention strategies.
Main Methods:
- Literature review of studies on cholesterol metabolism and CRC.
- Analysis of meta-analyses and pharmacogenetic data.
- Inclusion of insights from molecular pathological epidemiology.
Main Results:
- Evidence confirms a strong association between cholesterol metabolism and CRC development.
- Molecular pathways linking cholesterol to CRC are being elucidated.
- Cholesterol-lowering interventions show potential in CRC prevention.
Conclusions:
- Cholesterol metabolism is a critical factor in colorectal cancer.
- Understanding these links can inform novel prevention and treatment strategies.
- Further research in molecular epidemiology is crucial for advancing CRC prevention.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...